Inositol hexaphosphate and inositol prevent WD/CCl₄-induced metabolic dysfunction-associated steatohepatitis in mice

Key Points

• Inositol hexaphosphate significantly reduces markers of oxidative stress in the liver, improving metabolic function.
• Key metrics indicate a decrease in liver fat accumulation and fibrosis in treated mice compared to controls.
• Assessment using metabolic markers and histological analysis shows effective protective effects against steatohepatitis.
• This study highlights the potential of inositol hexaphosphate in preventing liver disease, emphasizing preclinical validation.